CEACAM1, a transmembrane protein acting in hepatocytes to get rid of insulin excess hence limiting insulin resistance, has been shown to be lower in T1D and could be the link between NAFLD and T1D (36). This evidence concerns the gene CEACAM1 and metabolic dysfunction-associated steatotic liver disease.